Furaltadone

DB16567InvestigationalSmall molecule

Furaltadone is indicated in combination with other drugs for the treatment of otitis media and externa. An ingredient in medications to treat ear infections.

Mechanism: Pharmacologically active on Tyrosine-protein kinase SYK and Tyrosine-protein kinase Lyn
Curator reviewed
Formula / weight: C₁₃H₁₆N₄O₆ · 324.293 g/mol (avg)
Also known as: (±)-5-(MORPHOLINOMETHYL)-3-((5-NITROFURFURYLIDENE)AMINO)-2-OXAZOLIDINONE
Code names: 205-384-5 · NSC-42388

Resolves to

Compound

UNII5X4V82ZN30CAS139-91-3ChEMBLCHEMBL1189513

Structure

InChIKeyYVQVOQKFMFRVGR-VGOFMYFVSA-NSMILES[O-][N+](=O)C1=CC=C(O1)\C=N\N1CC(CN2CCOCC2)OC1=O

Targets

P43405SYKP07948LYN

What you can answer from here — as of August 31, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Marketed productsAcross 1 country and 3 labellers

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Furaltadone, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account